Privatisation
Low Keng Huat controlling shareholders up offer price to S$0.78 per share, extend closing date
Revised offer represents an increase of 8.3% or S$0.06 over the initial offer price
CEO of Salonpas maker seeks to take the 450 billion yen drug firm private
The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ages
Can Singapore family-owned property empires last far beyond three generations?
Applying lessons from Geneva’s Pictet family
Concerns of weak prospects at Low Keng Huat belie a history of strong shareholder returns
Its shares have delivered a higher total return over the past 15 years than the STI as well as property groups such as CDL, Hongkong Land and UOL
Owning luxury hotels is tough but can be richly rewarding for patient capital
Jardine Matheson and Frasers Property could gain from hotel ownership over the long term
Temasek-backed consortium to take China’s ANE private at HK$14.33 billion valuation
[SINGAPORE/HONG KONG] ANE (Cayman) said on Tuesday (Oct 28) a consortium comprising its largest shareholder, Centurium Capital, Temasek Holdings and True Light have offered to take it private in a dea...
Temasek-led consortium makes offer to delist China’s ANE in Hong Kong
The consortium is working with advisers on the take-private proposal, but the negotiations have been challenging
Genting Bhd moves to privatise Genting Malaysia in RM6.7 billion deal
The conglomerate says the deal would improve capital allocation and operational efficiency
HSBC plans to privatise Hang Seng at US$37 billion valuation
The lender plans to refrain from share buybacks in the coming three quarters as it seeks to restore its capital ratio to its operating range
Competition watchdog clears Econ Healthcare acquisition, says deal has not substantially lessened competition
This is in view of the low market shares of the parties involved in the acquisition, among other reasons
